Arcadia Biosciences Balance Sheet - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.97 $0.02 (1.92%) RKDA stock closing price Feb 24, 2017 (Closing)

The fundamental analysis of this company requires a thorough look at Arcadia Biosciences balance sheet. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Arcadia Biosciences stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Arcadia Biosciences had a long term debt of $24.93M at the end of 2015. Arcadia Biosciences operating cash flow was $-15.1M while Arcadia Biosciences revenue stood at $5.41M. View latest and last 10 year balance sheet data to check Arcadia Biosciences financial performance..

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Cash23.97M16.57M2.83M
Marketable Securities26.27M--
Receivables0.78M1.42M1.02M
Inventory0.29M0.42M0.45M
Raw Materials---
Work In Progress---
Finished Goods---
Notes Receivable---
Other Current Assets0.69M0.27M0.25M
Arcadia Biosciences Total Current Assets
52.01M18.69M4.56M
Property Plant & Equipment5.24M5.38M5.27M
Accumulated Depreciation4.65M4.65M4.33M
Arcadia Biosciences Net Property Plant & Equipment
0.58M0.72M0.94M
Investment & Advances19.74M0.5M1.43M
Other Non-Current Assets1.86M2.14M2.53M
Deferred Charges---
Intangibles---
Deposits & Other Assets0.02M2.81M0.06M
Arcadia Biosciences Total Assets
74.24M24.88M9.54M
Notes Payable-5.6M4.56M
Accounts Payable2.42M3.19M2.51M
Current Portion Long-Term Debt---
Current Portion Capital Leases---
Accrued Expenses---
Income Taxes Payable---
Other Current Liabilities1.02M2.46M2.46M
Arcadia Biosciences Total Current Liabilities
3.45M11.26M9.54M
Mortgages---
Deferred Taxes/Income2.63M3.63M4.37M
Convertible Debt---
Long-Term Debt24.93M8.86M9.92M
Non-Current Capital Leases---
Other Long-Term Liabilities3M3M3M
Arcadia Biosciences Total Liabilities
34.01M26.77M26.83M
Minority Interest---
Preferred Stock-82.88M-
Common Stock Net0.04M--
Capital Surplus172.22M29.2M78.33M
Retained Earnings-131.92M-113.97M-95.63M
Treasury Stock---
Other Liabilities-0.11M--
Arcadia Biosciences Shareholders Equity
40.22M-1.88M-17.29M
Arcadia Biosciences Total Liabilities & Shareholders Equity
74.24M24.88M9.54M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Balance sheet for another ticker

Most investors just check the Arcadia Biosciences stock price, and Arcadia Biosciences historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Arcadia Biosciences PE ratio chart. Below is a brief explanation of common balance sheet terms:
  • Assets: Anything that the Arcadia Biosciences company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Arcadia Biosciences had total assets of $74.24M.
  • Liabilities: The total liabilities of Arcadia Biosciences for 2015 total to $34.01M. Liabilities for a company like Arcadia Biosciences include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.
.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
14.57
Debt to Equity ratio
0.91
Asset Turnover
ratio
0.07
receivables turnover
ratio
6.49
PB ratio (
price to book ratio
)
1.2070